Trial Profile

OnabotulinumtoxinA (Botox) Effect on Pain and Return to Sport in Chronic Exertional Compartment Syndrome of the Anterior Leg: A Pilot Study

Status: Discontinued

Phase of Trial: Phase I/II

Latest Information Update: 20 Feb 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Botulinum-Toxin-A (Primary)
Indications Compartment syndrome; Musculoskeletal pain
Focus Adverse reactions; Therapeutic Use

Most Recent Events

08 Feb 2023 Status changed from completed to discontinued, due to COVID-19.
26 Apr 2022 Status changed from recruiting to completed.
13 Aug 2021 The primary endpoint was changed from Decrease in pain as assessed by change in Sliding pain scale to Change in Pain Score, Number of Participants with Lower Extremity Weakness, and Incidence of Adverse Events, according to ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com